One of the primary benefits of ICTs is the improved ability to collect, analyze, and use data. But to do this well and sustainably requires fostering a data use culture. In this paper, we explore two frameworks that PATH has developed to highlight the necessary components of a data use culture-at a national system or country level as well as at organization, facility, community, or individual levels. We also present recommendations for how the digital health field can take local, regional, and global action to accelerate the rate at which countries and communities are designing and building their own data use cultures.

Author: Arenth B, Bennett A, Bernadotte C, Carnahan E, Dube M, Thompson J, Walton J. Goertz H, ed.

Publication date: October 2017

Region: Global

Progress made in protecting Americans and people around the world from pandemics is at risk of being lost if funding is not sustained. This report provides analysis of the importance of developing a robust pipeline of new drugs, diagnostics, vaccines, and other technologies for diseases likely to become pandemics, and outlines recommendations for action from the US government to prevent the next pandemic.

Author: Banin E

Publication date: October 2017

Region: Global

Vitamins and minerals are essential for healthy growth and development, especially for children and women. This fact sheet describes PATH and partners development of a multiplexed diagnostic panel to support surveillance of micronutrient deficiencies and further support vaccination efforts.

Publication date: October 2017

Region: Global

Subcutaneous DMPA (DMPA-SC, Sayana® Press) is a new, easy-to-use injectable contraceptive that is ideally suited for remote access and even self-injection. This brief provides an overview of PATH’s Self-Injection Best Practices project, which aims to evaluate and identify optimal program models for self-injection of DMPA-SC. For more information, please visit our Reproductive Health Global Program website.

Publication date: October 2017

Region: Global

Part of series: Sayana Press (DMPA-SC in Uniject) introduction and research fact sheets

Pregnant women in low- and middle-income countries have inadequate access to lifesaving maternal health products, resulting in preventable deaths when complications arise during pregnancy or childbirth. Healthy markets are essential to improving access to these products. This series of advocacy papers provides specific and actionable recommendations that advocates and decision-makers—globally and in three target countries:  Bangladesh, Ethiopia, and Nigeria—can use to raise awareness of the urgent actions needed and push for positive policy change to improve the quality and availability of essential maternal health products.

Publication date: October 2017

Region: Africa, Asia, Global

This fact sheet outlines the Advancing Maternal Immunization (AMI) collaboration, which brings together diverse stakeholders to improve infant health and survival through maternal immunization. Currently focused on respiratory syncytial virus, AMI is identifying viable pathways to enable informed decision-making and rapid launch of maternal vaccines, particularly in resource-limited settings.

Publication date: September 2017

Region: Global

Partnering with Tanzania and Zambia, the BID Initiative developed, tested, and rolled out interventions that address some of the most pressing routine immunization service delivery challenges, such as poor visibility into vaccine supplies and difficulty identifying children who default on immunization schedules. These briefs summarize the BID Initiative’s approaches and interventions, and shares recommendations and lessons learned for others interested in improving immunization data quality and use.

Publication date: September 2017

Region: Global

Part of series: BID Initiative Briefs

Partnering with Tanzania and Zambia, the BID Initiative developed, tested, and rolled out interventions that address some of the most pressing routine immunization service delivery challenges, such as poor visibility into vaccine supplies and difficulty identifying children who default on immunization schedules. These briefs summarize the BID Initiative’s approaches and interventions, and shares recommendations and lessons learned for others interested in improving immunization data quality and use.

Publication date: September 2017

Region: Global

Part of series: BID Initiative Briefs

Partnering with Tanzania and Zambia, the BID Initiative developed, tested, and rolled out interventions that address some of the most pressing routine immunization service delivery challenges, such as poor visibility into vaccine supplies and difficulty identifying children who default on immunization schedules. These briefs summarize the BID Initiative’s approaches and interventions, and shares recommendations and lessons learned for others interested in improving immunization data quality and use.

Publication date: September 2017

Region: Global

Part of series: BID Initiative Briefs

Partnering with Tanzania and Zambia, the BID Initiative developed, tested, and rolled out interventions that address some of the most pressing routine immunization service delivery challenges, such as poor visibility into vaccine supplies and difficulty identifying children who default on immunization schedules. These briefs summarize the BID Initiative’s approaches and interventions, and shares recommendations and lessons learned for others interested in improving immunization data quality and use.

Publication date: September 2017

Region: Global

Part of series: BID Initiative Briefs

Partnering with Tanzania and Zambia, the BID Initiative developed, tested, and rolled out interventions that address some of the most pressing routine immunization service delivery challenges, such as poor visibility into vaccine supplies and difficulty identifying children who default on immunization schedules. These briefs summarize the BID Initiative’s approaches and interventions, and shares recommendations and lessons learned for others interested in improving immunization data quality and use.

Publication date: September 2017

Region: Global

Part of series: BID Initiative Briefs

Partnering with Tanzania and Zambia, the BID Initiative developed, tested, and rolled out interventions that address some of the most pressing routine immunization service delivery challenges, such as poor visibility into vaccine supplies and difficulty identifying children who default on immunization schedules. These briefs summarize the BID Initiative’s approaches and interventions, and shares recommendations and lessons learned for others interested in improving immunization data quality and use.

Publication date: September 2017

Region: Global

Part of series: BID Initiative Briefs

Partnering with Tanzania and Zambia, the BID Initiative developed, tested, and rolled out interventions that address some of the most pressing routine immunization service delivery challenges, such as poor visibility into vaccine supplies and difficulty identifying children who default on immunization schedules. These briefs summarize the BID Initiative’s approaches and interventions, and shares recommendations and lessons learned for others interested in improving immunization data quality and use.

Publication date: September 2017

Region: Global

Part of series: BID Initiative Briefs

Partnering with Tanzania and Zambia, the BID Initiative developed, tested, and rolled out interventions that address some of the most pressing routine immunization service delivery challenges, such as poor visibility into vaccine supplies and difficulty identifying children who default on immunization schedules. These briefs summarize the BID Initiative’s approaches and interventions, and shares recommendations and lessons learned for others interested in improving immunization data quality and use.

Publication date: September 2017

Region: Global

Part of series: BID Initiative Briefs

Eliminating malaria requires collaboration across borders, sectors, and disciplines. PATH engages partners in the public, private, and nonprofit sectors to develop, evaluate, and scale tools and strategies to defeat malaria. Our partnership model translates bold ideas into products and strategies, and leverages national capacity in the fight against malaria.

Author: Bilak H, Steketee R

Publication date: September 2017

Region: Global

Part of series: Malaria learning series

Part of the Technology Updates series, this fact sheet describes PATH's work, in collaboration with MSR® Global Health, to develop the SE Flow, an innovative onsite chlorine generator for drinking water treatment and infection prevention and control.

Publication date: September 2017

Region: Global

Part of series: Technology Updates

The Coalition for Access to NCD Medicines and Products is dedicated to increasing access to essential medicines and health products (EMPs) for noncommunicable diseases (NCDs) to reduce the impact of diseases such as diabetes, hypertension, and cardiovascular disease.

Publication date: September 2017

Region: Global

This fact sheet describes the work and approach of the Typhoid Vaccine Acceleration Consortium (TyVAC), a partnership between the Center for Vaccine Development at the University of Maryland, the Oxford Vaccine Group at Oxford University, and PATH. TyVAC aims to accelerate the introduction of new typhoid conjugate vaccines as part of an integrated approach to reduce the burden of typhoid.

Publication date: August 2017

Region: Global

Since the beginning of the pandemic, PATH has worked in more than 35 countries to reduce the global impact of HIV/AIDs. This fact sheet outlines the range of PATH’s work to address HIV/AIDS, from developing new diagnostics to improving service delivery.

Publication date: August 2017

Region: Global

PATH and partners are developing iOWH032 as a complement to oral rehydration solution for diarrheal disease treatment. Acting via inhibition of the cystic fibrosis transmembrane conductance regulator chloride channel, iOWH032 is a novel, low-molecular-weight compound intended to reduce fluid and electrolyte loss in cases of cholera toxin-induced secretory diarrhea.

Publication date: August 2017

Region: Global